Inventor · disambiguated record
Wei-Guo Su
Also filed as: SU WEI G · SU WEI-GUO
43 granted patents·21 pending applications·525 citations·filing 1995–2025
97Inventor score
Files withHUTCHISON MEDIPHARMA LTD31PFIZER11SU WEI-GUO8HUTCHISON MEDIPHARMA ENTPR LTD7AGOURON PHARMA2
Top patents by PatentIndex Score
64 records- 0199US5834450A9- (substituted amino) -alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibioticsPFIZER·Filed 1995·Granted Nov 10, 1998·252 cites·8 claims
- 0293US8507487B2Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use thereforSU WEI-GUO·Filed 2012·Granted Aug 13, 2013·17 cites·4 claims
- 0389US2025099462A1Certain Triazolopyridines and Triazolopyrazines, Compositions Thereof and Methods of Use ThereforHUTCHISON MEDIPHARMA LTD·Filed 2024·Application pending·0 cites
- 0488US2024139182A1Certain Triazolopyridines and Triazolopyrazines, Compositions Thereof and Methods of Use ThereforHUTCHISON MEDIPHARMA LTD·Filed 2023·Application pending·0 cites
- 0587US9346810B2Pyrrolopyrimidine compounds and uses thereofSU WEI-GUO·Filed 2011·Granted May 24, 2016·11 cites·6 claims
- 0687US6555524B2Ketolide antibioticsPFIZER·Filed 2001·Granted Apr 29, 2003·34 cites·7 claims
- 0786US6849608B2Macrolide antibioticsPFIZER·Filed 2003·Granted Feb 1, 2005·24 cites·6 claims
- 0886US6025350AC-4" substituted macrolide antibioticsPFIZER·Filed 1998·Granted Feb 15, 2000·36 cites·10 claims
- 0983US10512645B2Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use thereforHUTCHISON MEDIPHARMA LTD·Filed 2018·Granted Dec 24, 2019·2 cites·18 claims
- 1082US9956218B2Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use thereforHUTCHISON MEDIPHARMA LTD·Filed 2016·Granted May 1, 2018·2 cites·10 claims
- 1182US8987269B2Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use thereforSU WEI-GUO·Filed 2010·Granted Mar 24, 2015·4 cites·17 claims
- 1282US8349859B2Pyrimidine derivativesHUTCHISON MEDIPHARMA ENTPR LTD·Filed 2008·Granted Jan 8, 2013·6 cites·12 claims
- 1382US6777543B213-methyl erythromycin derivativesPFIZER·Filed 2003·Granted Aug 17, 2004·16 cites·5 claims
- 1481US8212033B2Use of substituted quinazoline compounds in treating angiogenesis-related diseasesSU WEI-GUO·Filed 2010·Granted Jul 3, 2012·5 cites·10 claims
- 1580US10946014B2Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use thereforHUTCHISON MEDIPHARMA LTD·Filed 2019·Granted Mar 16, 2021·0 cites·2 claims
- 1680US8901143B2Pyrimidine derivativesHUTCHISON MEDIPHARMA ENTPR LTD·Filed 2012·Granted Dec 2, 2014·5 cites·11 claims
- 1779US10208066B2Imidazopyridazine compounds and their useHUTCHISON MEDIPHARMA LTD·Filed 2015·Granted Feb 19, 2019·4 cites·16 claims
- 1878US2024301077A1Anti-ox40 antibody and uses thereofHUTCHISON MEDIPHARMA LTD·Filed 2024·Application pending·0 cites
- 1977US12234211B2Cycloolefin substituted heteroaromatic compounds and their useHUTCHISON MEDIPHARMA LTD·Filed 2022·Granted Feb 25, 2025·0 cites·15 claims
- 2077US10052330B2Substituted pyrido[3,4-b]pyrazines as Syk inhibitorsHUTCHISON MEDIPHARMA LTD·Filed 2016·Granted Aug 21, 2018·2 cites·34 claims
- 2176US12030951B2Anti-OX40 antibody and uses thereofHUTCHISON MEDIPHARMA LTD·Filed 2022·Granted Jul 9, 2024·0 cites·13 claims
- 2276US11896592B2Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use thereforHUTCHISON MEDIPHARMA LTD·Filed 2021·Granted Feb 13, 2024·0 cites·12 claims
- 2374US9434726B2Substituted pyrido[3,4-b]pyrazines as Syk inhibitorsSU WEI-GUO·Filed 2012·Granted Sep 6, 2016·2 cites·28 claims
- 2474US6664238B1Carbamate and carbazate ketolide antibioticsPFIZER·Filed 1999·Granted Dec 16, 2003·35 cites·10 claims
- 2574US2025223267A1Cycloolefin substituted heteroaromatic compounds and their useHUTCHISON MEDIPHARMA LTD·Filed 2025·Application pending·0 cites
- 2673US9701680B2Pyrimidine and pyridine compounds and their usageHUTCHISON MEDIPHARMA LTD·Filed 2014·Granted Jul 11, 2017·2 cites·23 claims
- 2772US7829574B2Substituted quinazoline compounds and their use in treating angiogenesis-related diseasesHUTCHISON MEDIPHARMA ENTPR LTD·Filed 2008·Granted Nov 9, 2010·1 cites·17 claims
- 2872US2025361223A1Amide compounds and uses thereofHUTCHISON MEDIPHARMA LTD·Filed 2025·Application pending·0 cites
- 2971US10111875B2Pyrrolopyrimidine compounds and uses thereofHUTCHISON MEDIPHARMA LTD·Filed 2016·Granted Oct 30, 2018·1 cites·23 claims
- 3071US8658658B2Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and useSU WEI-GUO·Filed 2010·Granted Feb 25, 2014·2 cites·26 claims
- 3170US8426430B2Quinazoline derivativesZHANG WEIHAN·Filed 2008·Granted Apr 23, 2013·2 cites·10 claims
- 3270US6300316B1C-4 substituted macrolide antibioticsPFIZER·Filed 1999·Granted Oct 9, 2001·25 cites·11 claims
- 3370US6262030B1Erythromycin derivativesPFIZER·Filed 1999·Granted Jul 17, 2001·26 cites·30 claims
- 3466US12435062B2Amide compounds and uses thereofHUTCHISON MEDIPHARMA LTD·Filed 2021·Granted Oct 7, 2025·0 cites·20 claims
- 3566US11414390B2Cycloolefin substituted heteroaromatic compounds and their useHUTCHISON MEDIPHARMA LTD·Filed 2018·Granted Aug 16, 2022·0 cites·9 claims
- 3666US7622465B2Costunolide derivativesHUTCHISON MEDIPHARMA ENTPR LTD·Filed 2008·Granted Nov 24, 2009·0 cites·21 claims
- 3766US2023242657A1Anti-ox40 antibody and uses thereofHUTCHISON MEDIPHARMA LTD·Filed 2021·Application pending·0 cites
- 3858US2022073642A1Methods of using surufatinib in treating advanced pancreatic and extra-pancreatic neuroendocrine tumorsHUTCHISON MEDIPHARMA LTD·Filed 2021·Application pending·0 cites
- 3957US10369153B2Pyrrolopyrimidine compounds and uses thereofHUTCHISON MEDIPHARMA LTD·Filed 2018·Granted Aug 6, 2019·0 cites·6 claims
- 4057US2015368271A1Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use thereforHUTCHISON MEDIPHARMA LTD·Filed 2015·Application pending·0 cites
- 4155US8497372B2Use of substituted quinazoline compounds in treating age-related macular degenerationSU WEI-GUO·Filed 2012·Granted Jul 30, 2013·0 cites·10 claims
- 4254US10611777B2Imidazopyridazine compounds and their useHUTCHISON MEDIPHARMA LTD·Filed 2018·Granted Apr 7, 2020·0 cites·19 claims
- 4354US2024002388A1Pyrimidinone compounds and uses thereofHUTCHISON MEDIPHARMA LTD·Filed 2021·Application pending·0 cites
- 4454US2023151110A1Anti-cd47 antibody and uses thereofHUTCHISON MEDIPHARMA LTD·Filed 2021·Application pending·0 cites
- 4554US2024092774A1Heteroaromatic compounds and uses thereofHUTCHISON MEDIPHARMA LTD·Filed 2021·Application pending·0 cites
- 4651US2017152258A9Substituted Pyridopyrazines as Syk InhibitorsHUTCHISON MEDIPHARMA LTD·Filed 2013·Application pending·0 cites
- 4750US12492210B2Tricyclic compounds and their useHUTCHISON MEDIPHARMA LTD·Filed 2020·Granted Dec 9, 2025·0 cites·40 claims
- 4850US2015291593A1Novel heteroaryl and heterocycle compounds, compositions and methodsHUTCHISON MEDIPHARMA LTD·Filed 2013·Application pending·0 cites
- 4949US2015307520A1Novel heteroaryl and heterocycle compounds, compositions and methods thereofHUTCHISON MEDIPHARMA LTD·Filed 2013·Application pending·0 cites
- 5049US2015307491A1Substituted pyridopyrazines as syk inhibitorsHUTCHISON MEDIPHARMA LTD·Filed 2012·Application pending·0 cites
Showing the top 50 of 64 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Wei-Guo Su files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →